期刊： THORACIC CANCER, 2021; 12 (14)
The treatment of stage IIIB non-small cell lung cancer (NSCLC) is complicated, the best strategy is chosen individually and surgery is usually not rec......
期刊： THORACIC CANCER, 2021; 12 (17)
Background Lung cancer accounts for the highest rate of cancer-related diagnosis and mortality. Lung adenocarcinoma (LUAD) is the most common histopat......
期刊： THORACIC CANCER, 2021; 12 (16)
Background Paraneoplastic syndrome is a distant effect caused by malignant tumors, which is related to the production of cellular immune response. The......
期刊： THORACIC CANCER, 2021; 12 (14)
Background: Lung cancer mainly includes non-small cell lung cancer (NSCLC). Lung adenocarcinoma (LUAD) is the main subtype of NSCLC. Long non-coding R......
期刊： THORACIC CANCER, 2021; 12 (17)
Background Lung cancer is one of the most common malignant tumors threatening human health. The aim of this study was to investigate the function of m......
期刊： THORACIC CANCER, 2021; 12 (12)
Background The cylindromatosis (CYLD) tumor suppressor is a microtubule-associated deubiquitinase that plays a critical role in the regulation of cell......
期刊： THORACIC CANCER, 2021; 12 (11)
Background Immune checkpoint inhibitors are a standard treatment for advanced lung cancer, although it remains important to identify biomarkers that c......
期刊： THORACIC CANCER, 2021; 12 (12)
Background Transbronchial lung biopsy (TBLB) is usually performed to obtain a definitive diagnosis for peripheral pulmonary lesions (PPLs). Ultrathin ......
期刊： THORACIC CANCER, 2021; 12 (15)
Background The prognosis for patients with stage II/III non-small cell lung cancer (NSCLC) is unsatisfactory, even after complete tumor resection and ......
期刊： THORACIC CANCER, 2021; 12 (11)
Background Little is known about the prognostic advantage of sex for pulmonary adenocarcinoma among Chinese patients. In this study, we aimed to inves......
期刊： THORACIC CANCER, 2021; 12 (12)
Anaplastic lymphoma kinase (ALK) rearrangements are drivers of a subset of non-small cell lung cancer (NSCLC). The rapid progression of ALK inhibitors......
期刊： THORACIC CANCER, 2021; 12 (13)
Background Circular RNAs (circRNAs) are covalently closed RNAs and are implicated in the development of non-small cell lung cancer (NSCLC). Here, we i......
期刊： THORACIC CANCER, 2021; 12 (12)
Background To investigate the survival benefit of concurrent chemoradiotherapy (CCRT) for patients with locally advanced esophageal squamous cell carc......
期刊： THORACIC CANCER, 2021; 12 (17)
Background tRNA-derived fragments (tRFs) have been found to play a regulatory role in the occurrence and development of many tumors. The aim of this s......
